Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, gamma -synuclein, and catechol-o-methyltransferase) identified by proteomic analysis. - Wikidata - awgldk - TriplyDB

Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, gamma -synuclein, and catechol-o-methyltransferase) identified by proteomic analysis.

Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, gamma -synuclein, and catechol-o-methyltransferase) identified by proteomic analysis.

http://www.wikidata.org/entity/Q45185168

about

Unconventional secretion of synuclein-γ promotes tumor cell invasion Gamma-Glutamylcyclotransferase: A Novel Target Molecule for Cancer Diagnosis and Treatment Multistrip Western blotting to increase quantitative data output.Urinary proteome of steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome of childhood.Human body fluid proteome analysis.Differential tissue-specific protein markers of vaginal carcinoma.Differential profiling of breast cancer plasma proteome by isotope-coded affinity tagging method reveals biotinidase as a breast cancer biomarker.Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen A panel of tumor markers, calreticulin, annexin A2, and annexin A3 in upper tract urothelial carcinoma identified by proteomic and immunological analysis O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation.Global proteomics and metabolomics in cancer biomarker discovery.siRNA-Mediated Suppression of Synuclein γ Inhibits MDA-MB-231 Cell Migration and Proliferation by Downregulating the Phosphorylation of AKT and ERK Neural protein gamma-synuclein interacting with androgen receptor promotes human prostate cancer progression Standardization of diagnostic biomarker concentrations in urine: the hematuria caveat.Expression of ERα, its ERαΔ3 Splice Variant and γ-SYNUCLEIN in Ovarian Cancer: A Pilot Study.Highly sensitive and specific novel biomarkers for the diagnosis of transitional bladder carcinoma.The impact of advanced proteomics in the search for markers and therapeutic targets of bladder cancer.Molecular biomarkers for cancer detection in blood and bodily fluids.Conventional and proteomic technologies for the detection of early stage malignancies: markers for ovarian cancer.Application of proteomic technology in eye research: a mini review.Targeting synuclein-gamma to counteract drug resistance in cancer.Synuclein-γ (SNCG) expression in ovarian cancer is associated with high-risk clinicopathologic disease.Urine gamma-synuclein as a biomarker for the diagnosis of bladder cancer.Urinary proteomics--a tool for biomarker discovery.Urine proteomics in kidney and urogenital diseases: Moving towards clinical applications.Proteome research in urothelial carcinoma.A Systematic Review of the Diagnostic and Prognostic Value of Urinary Protein Biomarkers in Urothelial Bladder Cancer Synuclein gamma protects HER2 and renders resistance to Hsp90 disruption.Synuclein γ protects Akt and mTOR and renders tumor resistance to Hsp90 disruption.Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study.alpha-Synuclein stimulates differentiation of osteosarcoma cells: relevance to down-regulation of proteasome activity.The contemporary role and impact of urine-based biomarkers in bladder cancer.Primary glioblastoma multiforme tumors and recurrence : Comparative analysis of the danger signals HMGB1, HSP70, and calreticulin.Establishment of an ELISA system for the determination of Japanese monkey calreticulin and its application to plasma samples in macaques.Extracellular gamma-synuclein promotes tumor cell motility by activating β1 integrin-focal adhesion kinase signaling pathway and increasing matrix metalloproteinase-24, -2 protein secretion.

P2860

Q24304136-3262979E-297D-4D9B-BBD6-9B63ECA795C2 Q26784527-3A02462F-4C3E-4966-8C04-F2BFE757927E Q31122708-9FD1D27B-F228-44A5-954E-1BE67502CD24 Q33246237-E14049D5-2294-458C-A633-D75B42264377 Q33262623-43F62DC3-CB9D-4857-A957-F7ADF6FEB227 Q33430245-E4D88A0E-D659-47D2-A62A-E05D719B0330 Q33546659-53FF7D85-3F15-4BDE-97B4-26A258B55D70 Q33626102-EC0C5DA8-8713-42E7-B4DC-47318B0881EF Q33689531-361F3092-FEA3-4B18-A526-3F37C7481DC5 Q33883510-C5C5A864-A6C6-4663-8752-6A2FB861471F Q34079038-B3209EC0-9508-4B98-A611-C1A8712991EF Q34340575-9F0AEAC5-24D9-4612-9733-ED446C25E9AA Q34508711-0F4F851C-76D2-4D87-83D5-1389273B109C Q34541867-713D421C-2386-45DF-9F45-4CC7F576FE8B Q35534334-55BB6632-EEB3-4E8B-A2EF-83F6A2F94FE1 Q35955378-9206C540-ABCE-47E7-A844-88CC00E23266 Q36323508-CC02C465-F5F0-4385-90F5-4041216B4374 Q36627755-A430829A-E4FA-4589-89FE-EA9D73421490 Q36686826-9B76EF44-C2F3-4755-889F-100E6B027BA8 Q37018105-5D94FE7C-F27E-4CBC-8216-047549618AD6 Q37030872-7120703D-D2DA-4C78-91CD-74F369F194E1 Q37391092-01FCAD6D-DD5C-4EEB-A812-1DB5FD976F74 Q37536597-964F1905-5523-41EF-8D9D-39D60A559B88 Q37701845-9D6FC4FA-87D7-41F4-8554-B4FCFC74AD05 Q37876853-52AA7880-F14E-4507-AF13-547AA05BA346 Q38461516-F91D32B2-67A0-4E79-B42D-28ABBE5BC202 Q38921522-F7487C14-3E60-48DA-8260-012A958E047A Q38977711-3B6A1934-54A2-4345-BD11-BFC6915C2602 Q38982175-0B3737D9-64DA-4C84-BE02-FB49D942F07F Q39123683-969203C1-8271-49FD-BD01-159CDFE8EEF9 Q40190309-08706DEA-92BF-45CE-A589-C213E4D08F3B Q47721208-E32CE92D-A1B9-4CFB-BE48-137AC76003CA Q52145169-904D1DF2-45A0-48DD-9FF7-B0BDF8508C18 Q54425356-7FB8B8EF-4BDF-43B8-9FB8-E1F3137DB10D Q55332346-0EDF958C-7641-4958-B70F-7FF69B2A1EA0

P2860

Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, gamma -synuclein, and catechol-o-methyltransferase) identified by proteomic analysis.

http://www.wikidata.org/entity/Q45185168

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Diagnostic potential in bladde ...... ntified by proteomic analysis.

@en

Diagnostic potential in bladde ...... ntified by proteomic analysis.

@nl

type

label

Diagnostic potential in bladde ...... ntified by proteomic analysis.

@en

Diagnostic potential in bladde ...... ntified by proteomic analysis.

@nl

prefLabel

Diagnostic potential in bladde ...... ntified by proteomic analysis.

@en

Diagnostic potential in bladde ...... ntified by proteomic analysis.

@nl

P1433

Q45185168-825EA721-C0E1-4F41-B288-0DCACDE2B78D

P1476

Q45185168-866DB155-D088-41A9-ADE8-E3BBF457346B

P2093

Q45185168-2442E053-D8F8-4B00-B69B-C0CD8AEA637D

Q45185168-28514FC1-7116-49EF-A1A2-68700088F109

Q45185168-2D6E195E-03E9-42FC-93D1-FFC0DF2DB655

Q45185168-764848A4-9B79-4182-9AA6-F06385F71AAC

Q45185168-AE0A1DC3-58D4-4651-8D65-95DAD966612A

Q45185168-B70B401F-B5A5-4DC8-8A8C-FC13F695F525

Q45185168-BA4D2F51-C3F2-412D-8CA3-607F73F4E885

Q45185168-BFF76EEA-40B5-4978-8ADB-9FB3D23388B6

Q45185168-DE159ADC-9472-44D4-84E5-0F460DC259BC

Q45185168-FDBDCE83-D4A4-47B5-9BC7-7ACB680ED0B9

P2860

Q45185168-01A9F0F0-35B5-423A-9D85-1A19CF8DE556

Q45185168-56067D68-A02F-4CDC-95FC-866D85CFDE14

Q45185168-6D41FFAA-A292-44A2-B55E-613E768A9DBA

Q45185168-6E38D416-A160-4CFE-AA9B-EAFE810B15EB

Q45185168-84ED7CA7-4B41-41C2-A2AB-04A57459AB23

Q45185168-9C28DEA4-1BA9-4A0B-984C-9D9673079E09

P304

Q45185168-6B3A105D-F4C7-4B68-B1B6-186F57FD8F32

P31

Q45185168-A619982F-8F46-4846-82F0-42AAEC43D6E7

P356

Q45185168-FCA39362-91B5-4BD3-9623-42603723F41E

P433

Q45185168-FA7CC195-3C22-45AA-8E1F-325D474DE2DD

P478

Q45185168-053C6A89-5200-4ACA-949C-A43330F0B280

P50

Q45185168-03A47931-51ED-486B-BB7B-2BE4701700B3

P577

Q45185168-1F41B558-9E79-4DA2-9E62-3933ABFFA5FC

P5875

Q45185168-4B8B2B63-EE35-4882-B739-EA30FB4B31AC

P698

Q45185168-31F63B12-39AC-4847-8EAD-20F0D7D13D2D

P921

Q45185168-2AFEFD72-01F2-4D0C-8B09-D2A64806D293

P356

J.1349-7006.2004.TB03183.X

P1433

P1476

Diagnostic potential in bladde ...... ntified by proteomic analysis.

@en

P2093

Akito Terai

http://www.w3.org/2001/XMLSchema#string

Hideaki Iwaki

http://www.w3.org/2001/XMLSchema#string

Hiroshi Iwamura

http://www.w3.org/2001/XMLSchema#string

Koji Yoshimura

http://www.w3.org/2001/XMLSchema#string

Mutsushi Kawakita

http://www.w3.org/2001/XMLSchema#string

Takahiro Isono

http://www.w3.org/2001/XMLSchema#string

Tatsuhiro Yoshiki

http://www.w3.org/2001/XMLSchema#string

Yoichi Arai

http://www.w3.org/2001/XMLSchema#string

Yoshihiko Wakabayashi

http://www.w3.org/2001/XMLSchema#string

Yusaku Okada

http://www.w3.org/2001/XMLSchema#string

P2860

Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary

Protein microarrays for gene expression and antibody screening.

Urine cytology. It is still the gold standard for screening?

Urine based markers of urological malignancy.

Tumor markers in the diagnosis of primary bladder cancer. A systematic review.

Micro total analysis systems. Recent developments.

P304

955-961

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1349-7006.2004.TB03183.X

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P50

Susumu Kageyama

P577

2004-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8133927

http://www.w3.org/2001/XMLSchema#string

P698

15596044

http://www.w3.org/2001/XMLSchema#string

P921